Form 4 Tracker
Edwards Lifesciences Corp
EW

62 insider filings · Latest: Oct 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 14, 2025Feb 14 9:11 PMLORANGER STEVEN R
Proposed Sale
5,739$76.42$438.6K—

View →

Feb 13, 2025Feb 13 9:05 PMLippis Daniel J.
Proposed Sale
500$76.34$38.2K—

View →

Feb 13, 2025Feb 13 9:04 PMSTONE HEISZ LESLIE
Proposed Sale
5,739$75.86$435.4K—

View →

Feb 13, 2025Feb 13 9:03 PMBOBO DONALD E JR
Proposed Sale
25,500$75.75$1.9M—

View →

Jan 16, 2025Jan 16 9:36 PMLippis Daniel J.
Proposed Sale
500$68.76$34.4K—

View →

Dec 16, 2024Dec 16 9:08 PMLippis Daniel J.
Proposed Sale
2,500$74.08$185.2K—

View →

Dec 9, 2024Dec 9 9:03 PMUllem Scott B.
Proposed Sale
33,750$71.68$2.4M—

View →

Dec 6, 2024Dec 6 9:14 PMMarkowitz Wayne
Proposed Sale
583$73.27$42.7K—

View →

Dec 6, 2024Dec 6 9:12 PMChopra Daveen
Proposed Sale
1,750$73.27$128.2K—

View →

Nov 13, 2024Nov 13 9:25 PMBOBO DONALD E JR
Proposed Sale
15,000$65.57$983.5K—

View →

Nov 5, 2024Nov 5 9:11 PMWood Larry L
Proposed Sale
25,000$65.91$1.6M—

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 8, 2026Oct 8 9:24 PMDaniel J. LippisCVP, TAVR
Option Exercise
619$72.683,095(D)

View →

Sep 11, 2026Sep 11 11:15 PMDaniel J. LippisCVP, TAVR
Option Exercise
619$72.683,714(D)

View →

Aug 26, 2026Aug 26 10:36 PMDaveen ChopraCVP, TMTT, Surgical & IHFM
Option Exercise
31,800$72.680(D)

View →

Aug 11, 2026Aug 11 9:07 PMDaniel J. LippisCVP, TAVR
Option Exercise
619$72.684,333(D)

View →

Jul 28, 2026Jul 28 11:40 PMWayne MarkowitzCVP, JAPAC
Option Exercise
9,628$74.029,628(D)

View →

Jul 9, 2026Jul 10 9:11 PMTheodora MistrasCVP, Chief Financial Officer
Grant/Award
74,125$91.3312,325(D)

View →

Jul 10, 2026Jul 10 9:04 PMDaniel J. LippisCVP, TAVR
Option Exercise
619$72.684,952(D)

View →

Jun 30, 2026Jul 1 12:01 AMDaniel J. LippisCVP, TAVR
Option Exercise
619$72.685,571(D)

View →

May 18, 2026May 18 9:29 PMDaniel J. LippisCVP, TAVR
Option Exercise
620$72.686,190(D)

View →

May 11, 2026May 12 8:55 PMBernard J ZovighianDirector, CEO
Option Exercise
47,207—0(D)

View →

May 11, 2026May 12 8:52 PMDonald E Bobo JRCVP,Strategy/Corp Development
Option Exercise
13,457—0(D)

View →

May 11, 2026May 12 8:50 PMDaveen ChopraCVP, TMTT & Surgical
Option Exercise
13,583—0(D)

View →

May 11, 2026May 12 1:59 AMScott B. UllemCVP, Chief Financial Officer
Option Exercise
19,830—0(D)

View →

May 7, 2026May 12 1:33 AMWayne MarkowitzCVP, JAPAC
Grant/Award
31,600$82.765,200(D)

View →

May 7, 2026May 12 1:32 AMBernard J ZovighianDirector, CEO
Grant/Award
289,100$82.7643,800(D)

View →

May 7, 2026May 9 1:17 AMDonald E Bobo JRCVP,Strategy/Corp Development
Grant/Award
51,850$82.767,850(D)

View →

May 7, 2026May 9 1:16 AMDaniel J. LippisCVP, TAVR
Grant/Award
47,750$82.767,850(D)

View →

May 7, 2026May 9 1:16 AMAndrew M. DahlSVP, Corporate Controller
Grant/Award
6,745$82.766,745(D)

View →

May 7, 2026May 9 1:16 AMDaveen ChopraCVP, TMTT & Surgical
Grant/Award
58,775$82.769,675(D)

View →

May 7, 2026May 9 1:15 AMAnnette BrulsCVP, EMEACLA
Grant/Award
40,350$82.766,650(D)

View →

Page 1 of 2

Next →